首页 > 最新文献

Nano Today最新文献

英文 中文
Graphene-based origami with bidirectional bending and folding 基于石墨烯的双向弯曲和折叠折纸
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-12-05 DOI: 10.1016/j.nantod.2025.102955
Jiwoo Kim , Donghoon Moon , Yoona Kim , Jae Hwan Jeong , Jaehyung Yu , Jangyup Son , Arend M. van der Zande , Gwan-Hyoung Lee
The precise fabrication and deformation of three-dimensional (3D) microstructures, such as origami and kirigami with folded features typically ranging from a few to several tens of micrometers, have gained significant interest owing to their versatility in advanced microfabrication processes. However, conventional approaches relying on flexible polymers or thin metals face limitations, such as unidirectional bending and poor spatial resolution in localized deformation. Here, we present a strategy to construct graphene-based origami structures by harnessing the mechanical properties of graphene and exploiting electron beam (e-beam)–induced deformation of graphene-polymer double layer. Poly(methyl methacrylate) (PMMA)/graphene bilayer films exhibit a significant shift in the neutral axis due to the high in-plane stiffness of graphene, enabling controlled bidirectional bending under selective e-beam irradiation. By sequential e-beam exposure on PMMA-based structures with spatially patterned graphene, we achieve complex 3D geometries, including flower- and crown-like motifs, as well as folding mechanisms such as chair-like pop-up designs and box-shaped enclosures. Furthermore, we demonstrate rotational motion in wheel-shaped structures, translating out-of-plane bending into in-plane rotation by the shortening effect. Our approach expands the design freedom and functional capabilities of microfabricated systems, offering a powerful platform for programmable, reconfigurable 3D architectures in microelectromechanical systems (MEMS), robotics, and soft materials.
三维(3D)微结构的精确制造和变形,如折纸和kirigami,其折叠特征通常从几微米到几十微米不等,由于其在先进微制造工艺中的多功能性而获得了极大的兴趣。然而,依靠柔性聚合物或薄金属的传统方法面临着局限性,例如单向弯曲和局部变形的空间分辨率差。在这里,我们提出了一种利用石墨烯的力学特性和电子束诱导石墨烯-聚合物双层变形来构建基于石墨烯的折纸结构的策略。由于石墨烯的高平面内刚度,聚甲基丙烯酸甲酯(PMMA)/石墨烯双层膜在中性轴上表现出显著的位移,从而在选择性电子束照射下实现可控的双向弯曲。通过连续的电子束照射pmma结构和空间模式的石墨烯,我们实现了复杂的3D几何形状,包括花朵和皇冠状的图案,以及折叠机制,如椅子状的弹出式设计和盒状的外壳。此外,我们还演示了轮形结构中的旋转运动,通过缩短效应将面外弯曲转化为面内旋转。我们的方法扩展了微制造系统的设计自由度和功能,为微机电系统(MEMS),机器人和软材料中的可编程,可重构3D架构提供了强大的平台。
{"title":"Graphene-based origami with bidirectional bending and folding","authors":"Jiwoo Kim ,&nbsp;Donghoon Moon ,&nbsp;Yoona Kim ,&nbsp;Jae Hwan Jeong ,&nbsp;Jaehyung Yu ,&nbsp;Jangyup Son ,&nbsp;Arend M. van der Zande ,&nbsp;Gwan-Hyoung Lee","doi":"10.1016/j.nantod.2025.102955","DOIUrl":"10.1016/j.nantod.2025.102955","url":null,"abstract":"<div><div>The precise fabrication and deformation of three-dimensional (3D) microstructures, such as origami and kirigami with folded features typically ranging from a few to several tens of micrometers, have gained significant interest owing to their versatility in advanced microfabrication processes. However, conventional approaches relying on flexible polymers or thin metals face limitations, such as unidirectional bending and poor spatial resolution in localized deformation. Here, we present a strategy to construct graphene-based origami structures by harnessing the mechanical properties of graphene and exploiting electron beam (e-beam)–induced deformation of graphene-polymer double layer. Poly(methyl methacrylate) (PMMA)/graphene bilayer films exhibit a significant shift in the neutral axis due to the high in-plane stiffness of graphene, enabling controlled bidirectional bending under selective e-beam irradiation. By sequential e-beam exposure on PMMA-based structures with spatially patterned graphene, we achieve complex 3D geometries, including flower- and crown-like motifs, as well as folding mechanisms such as chair-like pop-up designs and box-shaped enclosures. Furthermore, we demonstrate rotational motion in wheel-shaped structures, translating out-of-plane bending into in-plane rotation by the shortening effect. Our approach expands the design freedom and functional capabilities of microfabricated systems, offering a powerful platform for programmable, reconfigurable 3D architectures in microelectromechanical systems (MEMS), robotics, and soft materials.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"67 ","pages":"Article 102955"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145682141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-step screening of lipid-polymer nanoparticles for efficient mRNA vaccine delivery and cancer immunotherapy 两步筛选用于有效mRNA疫苗递送和癌症免疫治疗的脂质聚合物纳米颗粒
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-12-06 DOI: 10.1016/j.nantod.2025.102943
Mengwen Huang , Chuhao Wang , Xiaojuan Wang , Dandan Chen , Jin Ling , Yue Yu , Miaomiao Zhang , Yucai Wang , Congfei Xu , Song Shen , Xianzhu Yang , Xiaojiao Du , Jun Wang
Messenger RNA (mRNA) vaccine is undoubtedly a medical breakthrough in drug development, however, its clinical application remains limited by inefficient delivery to target tissues and cells. In this study, we proposed a two-step screening strategy to optimize in vivo mRNA delivery system. First, we used the clinically approved cationic lipid, ionizable lipid and amphiphilic polymer to construct an initial library of lipid-polymer particles (LPP) with 60 various formulations for in vivo evaluation of their transfection efficiencies. Based on the results, we further constructed another library of 15 formulations to screen more effective LPPs. Then, the optimized LPP was selected and proved to be capable of effectively delivering mRNA to antigen-presenting cells (APCs), activating immune effector cells to trigger Th1/Th2 immune response, and promoting the formation of antigen-specific immune memory T cells. More importantly, LPP loaded with mRNA vaccine exhibited potent antitumor effects in both B16F10-OVA tumor model and human papillomavirus (HPV)-related TC-1 tumor model, exhibited comparable therapeutic activity to that of lipid nanoparticles (LNP) following intravenous injection. This study provides an innovative paradigm for the development of efficient mRNA delivery systems with high efficacy, safety, and clinical translation potential.
信使RNA (mRNA)疫苗无疑是药物开发的医学突破,但其临床应用仍然受到靶向组织和细胞递送效率低下的限制。在这项研究中,我们提出了一个两步筛选策略来优化mRNA在体内的传递系统。首先,我们使用临床批准的阳离子脂质、可电离脂质和两亲性聚合物构建了一个具有60种不同配方的脂质-聚合物颗粒(LPP)的初始文库,以在体内评估其转染效率。在此基础上,我们进一步构建了另一个包含15个配方的库,以筛选更有效的LPPs。然后,选择优化后的LPP并证明其能够有效地将mRNA传递给抗原提呈细胞(APCs),激活免疫效应细胞触发Th1/Th2免疫应答,促进抗原特异性免疫记忆T细胞的形成。更重要的是,负载mRNA疫苗的LPP在B16F10-OVA肿瘤模型和人乳头瘤病毒(HPV)相关TC-1肿瘤模型中均表现出强大的抗肿瘤作用,其治疗活性与静脉注射脂质纳米颗粒(LNP)相当。这项研究为开发高效、安全和具有临床翻译潜力的mRNA传递系统提供了一个创新的范例。
{"title":"Two-step screening of lipid-polymer nanoparticles for efficient mRNA vaccine delivery and cancer immunotherapy","authors":"Mengwen Huang ,&nbsp;Chuhao Wang ,&nbsp;Xiaojuan Wang ,&nbsp;Dandan Chen ,&nbsp;Jin Ling ,&nbsp;Yue Yu ,&nbsp;Miaomiao Zhang ,&nbsp;Yucai Wang ,&nbsp;Congfei Xu ,&nbsp;Song Shen ,&nbsp;Xianzhu Yang ,&nbsp;Xiaojiao Du ,&nbsp;Jun Wang","doi":"10.1016/j.nantod.2025.102943","DOIUrl":"10.1016/j.nantod.2025.102943","url":null,"abstract":"<div><div>Messenger RNA (mRNA) vaccine is undoubtedly a medical breakthrough in drug development, however, its clinical application remains limited by inefficient delivery to target tissues and cells. In this study, we proposed a two-step screening strategy to optimize in vivo mRNA delivery system. First, we used the clinically approved cationic lipid, ionizable lipid and amphiphilic polymer to construct an initial library of lipid-polymer particles (LPP) with 60 various formulations for in vivo evaluation of their transfection efficiencies. Based on the results, we further constructed another library of 15 formulations to screen more effective LPPs. Then, the optimized LPP was selected and proved to be capable of effectively delivering mRNA to antigen-presenting cells (APCs), activating immune effector cells to trigger Th1/Th2 immune response, and promoting the formation of antigen-specific immune memory T cells. More importantly, LPP loaded with mRNA vaccine exhibited potent antitumor effects in both B16F10-OVA tumor model and human papillomavirus (HPV)-related TC-1 tumor model, exhibited comparable therapeutic activity to that of lipid nanoparticles (LNP) following intravenous injection. This study provides an innovative paradigm for the development of efficient mRNA delivery systems with high efficacy, safety, and clinical translation potential.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"67 ","pages":"Article 102943"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145682142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endogenous enzyme-activatable catalytic DNA nanodevice for cancer cell-selective piRNA imaging and regulation 内源性酶激活催化DNA纳米器件用于癌细胞选择性piRNA成像和调控
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-12-04 DOI: 10.1016/j.nantod.2025.102950
Ke Qin, Jiayin Zhao, Fei Ma, Chun-yang Zhang
As the newly identified epigenetic regulators, piwi-interacting RNAs (piRNAs) are garnering increasing attention due to their potential implications in tumorigenesis. However, cancer cell-selective detection and regulation of cancer-associated piRNAs remains a significant challenge because of their broad distribution in both malignant and normal cells. Herein, we develop an endogenous enzyme-activatable catalytic DNA nanodevice (EE-CDN) for cell-selective imaging and regulation of piRNA. The EE-CDN remains inert in normal cells, which minimizes nonspecific background signal and avoids unwanted side effects. The EE-CDN can be activated only in cancer cells to enable cell-specific piRNA recognition. By anchoring the sensing elements onto a tetrahedral DNA scaffold, the EE-CDN allows amplified detection of piRNA with accelerated kinetics via spatially confined catalytic DNA assembly. Taking advantage of single-molecule detection, the EE-CDN can achieve attomolar sensitivity, enabling accurate discrimination and molecular subtyping of breast cancer in both cellular models and clinical tissue specimens. Importantly, the EE-CDN can facilitate in vivo tracking of piRNA in living breast cancer cells and breast cancer-bearing mice with superior spatial specificity, and it can efficiently suppress tumor growth in cells and mice models via depletion of endogenous piRNA, offering a powerful platform for precise diagnosis of cancer and targeted therapy.
piwi相互作用rna (piRNAs)作为新发现的表观遗传调控因子,因其在肿瘤发生中的潜在作用而受到越来越多的关注。然而,癌症相关pirna的癌细胞选择性检测和调控仍然是一个重大挑战,因为它们在恶性和正常细胞中广泛分布。在此,我们开发了一种内源性酶激活催化DNA纳米装置(EE-CDN),用于细胞选择性成像和调节piRNA。EE-CDN在正常细胞中保持惰性,从而最大限度地减少非特异性背景信号并避免不必要的副作用。EE-CDN只能在癌细胞中激活,以实现细胞特异性piRNA识别。通过将传感元件固定在四面体DNA支架上,EE-CDN可以通过空间受限的催化DNA组装加速动力学放大piRNA的检测。利用单分子检测的优势,EE-CDN可以实现原子摩尔灵敏度,从而在细胞模型和临床组织标本中实现乳腺癌的准确鉴别和分子分型。重要的是,EE-CDN能够以优越的空间特异性促进活的乳腺癌细胞和乳腺癌小鼠体内piRNA的跟踪,并能通过消耗内源性piRNA有效抑制细胞和小鼠模型中的肿瘤生长,为癌症的精确诊断和靶向治疗提供强大的平台。
{"title":"Endogenous enzyme-activatable catalytic DNA nanodevice for cancer cell-selective piRNA imaging and regulation","authors":"Ke Qin,&nbsp;Jiayin Zhao,&nbsp;Fei Ma,&nbsp;Chun-yang Zhang","doi":"10.1016/j.nantod.2025.102950","DOIUrl":"10.1016/j.nantod.2025.102950","url":null,"abstract":"<div><div>As the newly identified epigenetic regulators, piwi-interacting RNAs (piRNAs) are garnering increasing attention due to their potential implications in tumorigenesis. However, cancer cell-selective detection and regulation of cancer-associated piRNAs remains a significant challenge because of their broad distribution in both malignant and normal cells. Herein, we develop an endogenous enzyme-activatable catalytic DNA nanodevice (EE-CDN) for cell-selective imaging and regulation of piRNA. The EE-CDN remains inert in normal cells, which minimizes nonspecific background signal and avoids unwanted side effects. The EE-CDN can be activated only in cancer cells to enable cell-specific piRNA recognition. By anchoring the sensing elements onto a tetrahedral DNA scaffold, the EE-CDN allows amplified detection of piRNA with accelerated kinetics via spatially confined catalytic DNA assembly. Taking advantage of single-molecule detection, the EE-CDN can achieve attomolar sensitivity, enabling accurate discrimination and molecular subtyping of breast cancer in both cellular models and clinical tissue specimens. Importantly, the EE-CDN can facilitate in vivo tracking of piRNA in living breast cancer cells and breast cancer-bearing mice with superior spatial specificity, and it can efficiently suppress tumor growth in cells and mice models via depletion of endogenous piRNA, offering a powerful platform for precise diagnosis of cancer and targeted therapy.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"67 ","pages":"Article 102950"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145682133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PNA aptamer-based bioreceptors for cardiac biomarker (cTnI) detection: Insight into the structural and stability-related aspects 基于PNA适配体的心脏生物标志物(cTnI)检测生物受体:洞察结构和稳定性相关方面
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-12-10 DOI: 10.1016/j.nantod.2025.102957
Francesco Basini , Abdellah Hambli , Subhankar Sahu , Rupali Bagale , Manova Santhosh Yesupatham , Christophe Ritzenthaler , David Montaigne , Eloise Woitrain , Henri Happy , Rabah Boukherroub , Wolfgang Knoll , Sabine Szunerits , Roberto Corradini
Aptamers, nucleic acid molecules that fold into specific three-dimensional structures, have been extensively used in the biosensing field to accomplish sensitive and specific monitoring of a wide range of biomarkers. Peptide nucleic acid (PNA), in this context, can be considered as a potential next-generation scaffold for aptamer synthesis and biomarker sensing, owing to its high stability in comparison to DNA counterparts. In this work, we investigated the performance of a series of PNA aptamers for monitoring of a prominent cardiac biomarker, cardiac troponin I (cTnI), using surface plasmon resonance (SPR) and showed that PNA sequences shorter than those previously reported for DNA can exhibit picomolar affinity, provided the essential structural features are preserved. Two different immobilization strategies (covalent and non-covalent) are validated in parallel for PNAs. The stability of sensor response in the presence of endonucleases such as DNase I was investigated further, as their occurrence in blood, plasma, and serum hydrolyses phosphodiester bonds and could be a limiting factor for point-of-care (PoC) application of DNA aptamers. Owing to their unnatural backbone, PNAs exhibited higher stability against DNase I in comparison to their DNA aptamer counterpart. Additionally, molecular dynamics (MD) simulations of DNA and PNA aptamers revealed similarities in their secondary structures, as well as distinctions in their propensity to adopt compact conformations. Overall, our findings not only provided a comprehensive framework for PNA design, surface functionalization, and cTnI biomarker detection using PNA-based bio-recognition scaffolds but also substantiated the biostability of PNAs, suggesting their high relevance for future PoC diagnostic applications.
核酸适体是一种折叠成特定三维结构的核酸分子,已被广泛应用于生物传感领域,以实现对各种生物标志物的敏感和特异性监测。在这种情况下,肽核酸(PNA)可以被认为是一种潜在的下一代适体合成和生物标志物传感支架,因为它与DNA相比具有很高的稳定性。在这项工作中,我们利用表面等离子体共振(SPR)研究了一系列PNA适体监测心脏生物标志物心肌肌钙蛋白I (cTnI)的性能,并表明PNA序列比先前报道的DNA序列短,只要保留基本结构特征,就可以表现出小摩尔亲和力。两种不同的固定策略(共价和非共价)在PNAs平行验证。在DNA酶I等内切酶存在的情况下,传感器反应的稳定性被进一步研究,因为它们存在于血液、血浆和血清中,可以水解磷酸二酯键,并可能成为即时(PoC)应用DNA适体的限制因素。由于它们的非自然骨架,与DNA适体相比,PNAs对DNA酶I表现出更高的稳定性。此外,DNA和PNA适配体的分子动力学(MD)模拟揭示了它们二级结构的相似性,以及它们倾向于采用紧凑构象的区别。总的来说,我们的研究结果不仅为PNA设计、表面功能化和使用基于PNA的生物识别支架检测cTnI生物标志物提供了一个全面的框架,而且证实了PNA的生物稳定性,这表明它们与未来PoC诊断应用具有很高的相关性。
{"title":"PNA aptamer-based bioreceptors for cardiac biomarker (cTnI) detection: Insight into the structural and stability-related aspects","authors":"Francesco Basini ,&nbsp;Abdellah Hambli ,&nbsp;Subhankar Sahu ,&nbsp;Rupali Bagale ,&nbsp;Manova Santhosh Yesupatham ,&nbsp;Christophe Ritzenthaler ,&nbsp;David Montaigne ,&nbsp;Eloise Woitrain ,&nbsp;Henri Happy ,&nbsp;Rabah Boukherroub ,&nbsp;Wolfgang Knoll ,&nbsp;Sabine Szunerits ,&nbsp;Roberto Corradini","doi":"10.1016/j.nantod.2025.102957","DOIUrl":"10.1016/j.nantod.2025.102957","url":null,"abstract":"<div><div>Aptamers, nucleic acid molecules that fold into specific three-dimensional structures, have been extensively used in the biosensing field to accomplish sensitive and specific monitoring of a wide range of biomarkers. Peptide nucleic acid (PNA), in this context, can be considered as a potential next-generation scaffold for aptamer synthesis and biomarker sensing, owing to its high stability in comparison to DNA counterparts. In this work, we investigated the performance of a series of PNA aptamers for monitoring of a prominent cardiac biomarker, cardiac troponin I (cTnI), using surface plasmon resonance (SPR) and showed that PNA sequences shorter than those previously reported for DNA can exhibit picomolar affinity, provided the essential structural features are preserved. Two different immobilization strategies (covalent and non-covalent) are validated in parallel for PNAs. The stability of sensor response in the presence of endonucleases such as DNase I was investigated further, as their occurrence in blood, plasma, and serum hydrolyses phosphodiester bonds and could be a limiting factor for point-of-care (PoC) application of DNA aptamers. Owing to their unnatural backbone, PNAs exhibited higher stability against DNase I in comparison to their DNA aptamer counterpart. Additionally, molecular dynamics (MD) simulations of DNA and PNA aptamers revealed similarities in their secondary structures, as well as distinctions in their propensity to adopt compact conformations. Overall, our findings not only provided a comprehensive framework for PNA design, surface functionalization, and cTnI biomarker detection using PNA-based bio-recognition scaffolds but also substantiated the biostability of PNAs, suggesting their high relevance for future PoC diagnostic applications.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"67 ","pages":"Article 102957"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145734042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatially confined multivalent aptamers in the cavity of a DNA nanocage against bacterial superantigens infection DNA纳米笼腔中空间限制的多价适体对抗细菌超级抗原感染
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-09-12 DOI: 10.1016/j.nantod.2025.102899
Mengxia Duan , Man Ding , Kuaile Wu , Zhouping Wang , Shijia Wu , Nuo Duan
Aptamers as single-strand oligonucleotides obtained through in vitro screening techniques exhibit significant application potential due to their high target specificity, strong binding affinity, and inherent inhibitory capabilities. However, the easy entanglement among single-strand aptamers and excessive flexibility remains a huge challenge for keep high binding capabilities and dispersed spatial positioning in practical applications. Herein, we rationally designed a DNA nanocage structure loaded with multiple neutralizing aptamers (DNC-Apt). The programmability and the spatial confinement effect of DNC enable multiple single-strand aptamers to be reasonably fixed in the ideal spatial positions and achieve enhanced structural stability. Taking the enterotoxin A and B (SEs) secreted by Staphylococcus aureus as model target, both molecular docking and the ELONA experiment confirmed that the neutralizing aptamers integrated by this strategy achieved binding to different antigenic epitopes on SEs rely on spatially dispersed positioning, and exhibited enhanced binding ability (∼ 6 fold). The PBMC cell proliferation experiment demonstrated that this strategy could mediate the binding of SEs to receptors, thereby reducing the proliferation of T cells and the release of pro-inflammatory factors. Furthermore, the application of DNC-Apt in mice significantly reduced the inflammatory response and tissue damage caused by SEs. In conclusion, our research provided a reference for enhancing the application ability of aptamers and offered new strategies for alleviating the toxicity of bacterial toxins.
通过体外筛选技术获得的核酸适体作为单链寡核苷酸,具有较高的靶向特异性、较强的结合亲和力和内在的抑制能力,具有重要的应用潜力。然而,在实际应用中,单链适体之间容易缠结,灵活性过大,对保持高结合能力和分散的空间定位仍然是一个巨大的挑战。为此,我们合理设计了装载多个中和适体(DNC-Apt)的DNA纳米笼结构。DNC的可编程性和空间约束效应使多个单链适配体能够合理地固定在理想的空间位置,增强结构稳定性。以金黄色葡萄球菌分泌的肠毒素A和B (SEs)为模型靶点,通过分子对接和ELONA实验证实,通过该策略整合的中和适体依靠空间分散定位实现了与se上不同抗原表位的结合,并表现出增强的结合能力(约6倍)。PBMC细胞增殖实验表明,该策略可以介导SEs与受体的结合,从而减少T细胞的增殖和促炎因子的释放。此外,DNC-Apt在小鼠中的应用显著降低了SEs引起的炎症反应和组织损伤。总之,我们的研究为提高适体的应用能力提供了参考,并为减轻细菌毒素的毒性提供了新的策略。
{"title":"Spatially confined multivalent aptamers in the cavity of a DNA nanocage against bacterial superantigens infection","authors":"Mengxia Duan ,&nbsp;Man Ding ,&nbsp;Kuaile Wu ,&nbsp;Zhouping Wang ,&nbsp;Shijia Wu ,&nbsp;Nuo Duan","doi":"10.1016/j.nantod.2025.102899","DOIUrl":"10.1016/j.nantod.2025.102899","url":null,"abstract":"<div><div>Aptamers as single-strand oligonucleotides obtained through <em>in vitro</em> screening techniques exhibit significant application potential due to their high target specificity, strong binding affinity, and inherent inhibitory capabilities. However, the easy entanglement among single-strand aptamers and excessive flexibility remains a huge challenge for keep high binding capabilities and dispersed spatial positioning in practical applications. Herein, we rationally designed a DNA nanocage structure loaded with multiple neutralizing aptamers (DNC-Apt). The programmability and the spatial confinement effect of DNC enable multiple single-strand aptamers to be reasonably fixed in the ideal spatial positions and achieve enhanced structural stability. Taking the enterotoxin A and B (SEs) secreted by <em>Staphylococcus aureus</em> as model target, both molecular docking and the ELONA experiment confirmed that the neutralizing aptamers integrated by this strategy achieved binding to different antigenic epitopes on SEs rely on spatially dispersed positioning, and exhibited enhanced binding ability (∼ 6 fold). The PBMC cell proliferation experiment demonstrated that this strategy could mediate the binding of SEs to receptors, thereby reducing the proliferation of T cells and the release of pro-inflammatory factors. Furthermore, the application of DNC-Apt in mice significantly reduced the inflammatory response and tissue damage caused by SEs. In conclusion, our research provided a reference for enhancing the application ability of aptamers and offered new strategies for alleviating the toxicity of bacterial toxins.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102899"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145047333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-invasive CRISPR/Cas9 nanocapsules specifically edit α-synuclein for effective Parkinson’s disease treatment 非侵入性CRISPR/Cas9纳米胶囊特异性编辑α-突触核蛋白,有效治疗帕金森病
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-09-30 DOI: 10.1016/j.nantod.2025.102903
Qingshan Yang , Yujing Sang , Nan Geng , Yang Liu , Dongya Zhang , Yan Zou , Meng Zheng
Parkinson’s disease (PD) is the most common movement disorders, affecting more than 1 % of the elderly population aged over 60 years old. Targeting the accumulation of the toxic protein α-synuclein (α-Syn) (SNCA) is a common therapeutic strategy for PD. CRISPR/Cas9 gene technology could provide an avenue to achieve reduced levels of this protein. However, the lack of effective and safe brain delivery vectors greatly hampers its applications for brain disorders. In this paper, we developed glucose directed single-particle nanocapsules that efficiently delivers CRISPR/Cas9 into targeted brain lesions to specifically edit the SNCA gene. Our CRISPR/Cas9 nanocapsules have a small size of 32 nm and formed with a polymeric shell which protects Cas9/sgRNA from enzymatic degradation. Benefitting from surface glucose decoration, our nanocapsules exhibited blood brain barrier (BBB) permeability and accumulation in brain lesions after intravenous administration. Additionally, CRISPR/Cas9 nanocapsules selectively reduced expression of the SNCA leading to down regulation of α-Syn protein, M1/M2 microglial re-polarization, amelioration of neuroinflammation and recovery of tryptophan hydroxylase (TH) in A53T transgenic mice. Importantly, CRISPR/Cas9 nanocapsules significantly improved performance of mice in a variety behavioral test with negligible side effects. Therefore, the CRISPR/Cas9 nanocapsules provides a versatile but potent platform for genetic engineering in brain disorders, especially genome mutations relevant to neuronal disease.
帕金森病(PD)是最常见的运动障碍,影响超过1 %的60岁以上老年人口。靶向毒性蛋白α-突触核蛋白(α-Syn) (SNCA)的积累是PD的常用治疗策略。CRISPR/Cas9基因技术可以提供降低这种蛋白水平的途径。然而,缺乏有效和安全的脑传递载体,极大地阻碍了其在脑疾病中的应用。在本文中,我们开发了葡萄糖定向单颗粒纳米胶囊,可以有效地将CRISPR/Cas9递送到靶向脑病变中,特异性编辑SNCA基因。我们的CRISPR/Cas9纳米胶囊具有32 nm的小尺寸,由聚合物外壳形成,可以保护Cas9/sgRNA免受酶促降解。得益于表面葡萄糖修饰,我们的纳米胶囊在静脉给药后表现出血脑屏障(BBB)的渗透性和脑病变的积聚。此外,CRISPR/Cas9纳米胶囊选择性地降低SNCA的表达,导致A53T转基因小鼠α-Syn蛋白下调、M1/M2小胶质细胞再极化、神经炎症改善和色氨酸羟化酶(TH)恢复。重要的是,CRISPR/Cas9纳米胶囊显著提高了小鼠在各种行为测试中的表现,副作用可以忽略不计。因此,CRISPR/Cas9纳米胶囊为大脑疾病,特别是与神经元疾病相关的基因组突变的基因工程提供了一个多功能但有效的平台。
{"title":"Non-invasive CRISPR/Cas9 nanocapsules specifically edit α-synuclein for effective Parkinson’s disease treatment","authors":"Qingshan Yang ,&nbsp;Yujing Sang ,&nbsp;Nan Geng ,&nbsp;Yang Liu ,&nbsp;Dongya Zhang ,&nbsp;Yan Zou ,&nbsp;Meng Zheng","doi":"10.1016/j.nantod.2025.102903","DOIUrl":"10.1016/j.nantod.2025.102903","url":null,"abstract":"<div><div>Parkinson’s disease (PD) is the most common movement disorders, affecting more than 1 % of the elderly population aged over 60 years old. Targeting the accumulation of the toxic protein α-synuclein (α-Syn) (<em>SNCA</em>) is a common therapeutic strategy for PD. CRISPR/Cas9 gene technology could provide an avenue to achieve reduced levels of this protein. However, the lack of effective and safe brain delivery vectors greatly hampers its applications for brain disorders. In this paper, we developed glucose directed single-particle nanocapsules that efficiently delivers CRISPR/Cas9 into targeted brain lesions to specifically edit the <em>SNCA</em> gene. Our CRISPR/Cas9 nanocapsules have a small size of 32 nm and formed with a polymeric shell which protects Cas9/sgRNA from enzymatic degradation. Benefitting from surface glucose decoration, our nanocapsules exhibited blood brain barrier (BBB) permeability and accumulation in brain lesions after intravenous administration. Additionally, CRISPR/Cas9 nanocapsules selectively reduced expression of the <em>SNCA</em> leading to down regulation of α-Syn protein, M1/M2 microglial re-polarization, amelioration of neuroinflammation and recovery of tryptophan hydroxylase (TH) in A53T transgenic mice. Importantly, CRISPR/Cas9 nanocapsules significantly improved performance of mice in a variety behavioral test with negligible side effects. Therefore, the CRISPR/Cas9 nanocapsules provides a versatile but potent platform for genetic engineering in brain disorders, especially genome mutations relevant to neuronal disease.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102903"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145217729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gas therapy in combating antimicrobial resistance: Mechanisms, synergistic strategies, and clinical translation challenges 气体疗法在对抗抗菌素耐药性:机制,协同策略,和临床翻译的挑战
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-12-15 DOI: 10.1016/j.nantod.2025.102960
Hongyang Lu , Wei He , Jiayu Li , Lingjun Zhang , Buyun Zhou , Qiang Zhou , Xiaowen Hu , Quazi T.H. Shubhra , Xiaosong He , Xiaojun Cai
The escalating prevalence of antimicrobial resistance (AMR), largely driven by the misuse and overuse of antibiotics, underscores the urgent need to explore alternative non-antibiotic therapeutic strategies. Gas therapy (GT), which utilizes gaseous signaling molecules (GSMs) such as carbon monoxide (CO), nitric oxide (NO), hydrogen sulfide (H2S), oxygen (O2), and hydrogen (H2), has emerged as a promising antimicrobial strategy. These GSMs possess several distinctive advantages, including rapid and unimpeded diffusion into bacterial cells and biofilms, diverse antimicrobial mechanisms—such as reactive species generation, metabolic interference, and immune modulation—and a minimal risk of inducing AMR. This review systematically elucidates the antibacterial and anti-biofilm mechanisms of GSMs, emphasizing their integration with advanced modalities such as photodynamic therapy (PDT), photothermal therapy (PTT), sonodynamic therapy (SDT), and chemodynamic therapy (CDT) to enhance efficacy. We focus on how these strategies enable the precise delivery and controlled release of GSMs, how the released gases synergistically enhance therapeutic efficacy, and how these therapeutic platforms exhibit strong potential in combating infections caused by MDR bacteria and biofilm-associated pathogens. Despite preclinical success, critical barriers—including gas toxicity risks, biofilm penetration limitations, and regulatory hurdles—impede clinical translation. We further discuss future directions, advocating for engineered gas-releasing biomaterials, multimodal synergistic platforms, and artificial intelligence-driven design to optimize therapeutic outcomes. By bridging microbiology, nanotechnology, and clinical practice, this work underscores the potential of GT to redefine infection management in the post-antibiotic era.
抗生素耐药性(AMR)的流行程度不断上升,主要是由于抗生素的误用和过度使用,这突出表明迫切需要探索其他非抗生素治疗策略。气体疗法(GT)利用气体信号分子(GSMs),如一氧化碳(CO)、一氧化氮(NO)、硫化氢(H2S)、氧气(O2)和氢气(H2),已成为一种有前途的抗菌策略。这些gsm具有几个独特的优势,包括快速和畅通无阻地扩散到细菌细胞和生物膜,多种抗菌机制,如反应性物种产生,代谢干扰和免疫调节,以及诱导AMR的风险最小。本文系统阐述了GSMs的抗菌和抗生物膜机制,强调了其与光动力疗法(PDT)、光热疗法(PTT)、声动力疗法(SDT)和化学动力疗法(CDT)等先进疗法的结合,以提高疗效。我们重点关注这些策略如何实现gsm的精确递送和控制释放,释放的气体如何协同提高治疗效果,以及这些治疗平台如何在对抗耐多药细菌和生物膜相关病原体引起的感染方面显示出强大的潜力。尽管在临床前取得了成功,但包括气体毒性风险、生物膜渗透限制和监管障碍在内的关键障碍阻碍了临床转化。我们进一步讨论了未来的方向,倡导工程气体释放生物材料,多模态协同平台和人工智能驱动的设计,以优化治疗结果。通过连接微生物学、纳米技术和临床实践,这项工作强调了GT重新定义后抗生素时代感染管理的潜力。
{"title":"Gas therapy in combating antimicrobial resistance: Mechanisms, synergistic strategies, and clinical translation challenges","authors":"Hongyang Lu ,&nbsp;Wei He ,&nbsp;Jiayu Li ,&nbsp;Lingjun Zhang ,&nbsp;Buyun Zhou ,&nbsp;Qiang Zhou ,&nbsp;Xiaowen Hu ,&nbsp;Quazi T.H. Shubhra ,&nbsp;Xiaosong He ,&nbsp;Xiaojun Cai","doi":"10.1016/j.nantod.2025.102960","DOIUrl":"10.1016/j.nantod.2025.102960","url":null,"abstract":"<div><div>The escalating prevalence of antimicrobial resistance (AMR), largely driven by the misuse and overuse of antibiotics, underscores the urgent need to explore alternative non-antibiotic therapeutic strategies. Gas therapy (GT), which utilizes gaseous signaling molecules (GSMs) such as carbon monoxide (CO), nitric oxide (NO), hydrogen sulfide (H<sub>2</sub>S), oxygen (O<sub>2</sub>), and hydrogen (H<sub>2</sub>), has emerged as a promising antimicrobial strategy. These GSMs possess several distinctive advantages, including rapid and unimpeded diffusion into bacterial cells and biofilms, diverse antimicrobial mechanisms—such as reactive species generation, metabolic interference, and immune modulation—and a minimal risk of inducing AMR. This review systematically elucidates the antibacterial and anti-biofilm mechanisms of GSMs, emphasizing their integration with advanced modalities such as photodynamic therapy (PDT), photothermal therapy (PTT), sonodynamic therapy (SDT), and chemodynamic therapy (CDT) to enhance efficacy. We focus on how these strategies enable the precise delivery and controlled release of GSMs, how the released gases synergistically enhance therapeutic efficacy, and how these therapeutic platforms exhibit strong potential in combating infections caused by MDR bacteria and biofilm-associated pathogens. Despite preclinical success, critical barriers—including gas toxicity risks, biofilm penetration limitations, and regulatory hurdles—impede clinical translation. We further discuss future directions, advocating for engineered gas-releasing biomaterials, multimodal synergistic platforms, and artificial intelligence-driven design to optimize therapeutic outcomes. By bridging microbiology, nanotechnology, and clinical practice, this work underscores the potential of GT to redefine infection management in the post-antibiotic era.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"67 ","pages":"Article 102960"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145786544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrophage-targeted polysaccharide nano-immunomodulators with spatial- and time-programmed drug release for cancer therapy 巨噬细胞靶向多糖纳米免疫调节剂,具有空间和时间编程的药物释放用于癌症治疗
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-09-10 DOI: 10.1016/j.nantod.2025.102893
Li Xu , Jiaqian Miao , Danni Xu , Xuan Mo , Junjie Wang , Sisi Chen , Bing Liu , Guangbo Ge , Xinyuan Zhu , Hongping Deng
Reprogramming tumor-associated macrophages (TAMs) represents a promising strategy to reverse tumor immunosuppressive microenvironment (TIME) for cancer immunotherapy. However, the deficiency of macrophage cells in solid tumors requires targeted drug delivery to accomplish efficient immune activation while reducing the adverse side-effects. Meanwhile, the negative feedback of TAM activation compromises immunotherapy efficacy by inducing T cell exhaustion. In this work, we report a type of macrophage-targeted polysaccharide nano-immunomodulators (Dex-RN) with spatial- and time-programmed drug release for cancer therapy by activating the TLR7/8 pathways and inhibiting the negative IDO pathway. Dex-RN exhibited high TAM targeting capability in vivo with 40.8 % for D10-RN and 44.3 % for D70-RN as compared with the control (19.0 %), and possessed fast TLR7/8 agonist but slow IDO inhibitor release kinetics to address the impact of the negative feedback of TLR7/8 pathway activation. Consequently, Dex-RN generated significantly enhanced macrophage M1 polarization efficiency with superior expression levels of cell surface markers and cytokines. In a 4T1 murine tumor model, Dex-RN showed enhanced tumor growth inhibition (66 %) compared with free drug mixture (43 %), and potentiated cancer immunotherapy by inducing macrophage M1 polarization, activating CD8+ T cells and inhibiting Treg cells. Thus, this work highlights the conception of a spatial- and time-programmed polysaccharide nano-immunomodulator for TAM-mediated cancer immunotherapy.
重编程肿瘤相关巨噬细胞(tam)是一种很有前途的策略,可以逆转肿瘤免疫抑制微环境(TIME),用于癌症免疫治疗。然而,实体肿瘤中巨噬细胞的缺乏需要靶向给药,以实现有效的免疫激活,同时减少不良副作用。同时,TAM激活的负反馈通过诱导T细胞衰竭而影响免疫治疗效果。在这项工作中,我们报道了一种巨噬细胞靶向多糖纳米免疫调节剂(Dex-RN),通过激活TLR7/8通路和抑制IDO负通路,具有空间和时间编程的药物释放,可用于癌症治疗。与对照组(19.0 %)相比,dexx - rn在体内表现出较高的TAM靶向能力,D10-RN为40.8% %,D70-RN为44.3% %,并且具有快速的TLR7/8激动剂但缓慢的IDO抑制剂释放动力学,以解决TLR7/8途径激活的负反馈影响。因此,Dex-RN显著提高了巨噬细胞M1极化效率,并提高了细胞表面标记物和细胞因子的表达水平。在4T1小鼠肿瘤模型中,Dex-RN对肿瘤生长的抑制作用(66% %)高于游离药物混合物(43% %),并通过诱导巨噬细胞M1极化、激活CD8+ T细胞和抑制Treg细胞来增强肿瘤免疫治疗。因此,这项工作强调了空间和时间编程的多糖纳米免疫调节剂用于tam介导的癌症免疫治疗的概念。
{"title":"Macrophage-targeted polysaccharide nano-immunomodulators with spatial- and time-programmed drug release for cancer therapy","authors":"Li Xu ,&nbsp;Jiaqian Miao ,&nbsp;Danni Xu ,&nbsp;Xuan Mo ,&nbsp;Junjie Wang ,&nbsp;Sisi Chen ,&nbsp;Bing Liu ,&nbsp;Guangbo Ge ,&nbsp;Xinyuan Zhu ,&nbsp;Hongping Deng","doi":"10.1016/j.nantod.2025.102893","DOIUrl":"10.1016/j.nantod.2025.102893","url":null,"abstract":"<div><div>Reprogramming tumor-associated macrophages (TAMs) represents a promising strategy to reverse tumor immunosuppressive microenvironment (TIME) for cancer immunotherapy. However, the deficiency of macrophage cells in solid tumors requires targeted drug delivery to accomplish efficient immune activation while reducing the adverse side-effects. Meanwhile, the negative feedback of TAM activation compromises immunotherapy efficacy by inducing T cell exhaustion. In this work, we report a type of macrophage-targeted polysaccharide nano-immunomodulators (Dex-RN) with spatial- and time-programmed drug release for cancer therapy by activating the TLR7/8 pathways and inhibiting the negative IDO pathway. Dex-RN exhibited high TAM targeting capability <em>in vivo</em> with 40.8 % for D10-RN and 44.3 % for D70-RN as compared with the control (19.0 %), and possessed fast TLR7/8 agonist but slow IDO inhibitor release kinetics to address the impact of the negative feedback of TLR7/8 pathway activation. Consequently, Dex-RN generated significantly enhanced macrophage M1 polarization efficiency with superior expression levels of cell surface markers and cytokines. In a 4T1 murine tumor model, Dex-RN showed enhanced tumor growth inhibition (66 %) compared with free drug mixture (43 %), and potentiated cancer immunotherapy by inducing macrophage M1 polarization, activating CD8<sup>+</sup> T cells and inhibiting Treg cells. Thus, this work highlights the conception of a spatial- and time-programmed polysaccharide nano-immunomodulator for TAM-mediated cancer immunotherapy.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102893"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145027657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redox-driven mechanoregulation of invasive TNBC cells using poly(tannic acid) nanospheres 利用聚单宁酸纳米球对侵袭性TNBC细胞的氧化还原驱动机制调控
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-10-06 DOI: 10.1016/j.nantod.2025.102907
Minhee Ku , Suhui Jeong , Nara Yoon , Hwain Myeong , Jinwon Kwon , Jaemoon Yang , Sungbaek Seo
Poly(tannic acid) (pTA) nanospheres, assembled from natural tannic acid molecules, exhibit strong intracellular antioxidant activity and effectively modulate the invasive behaviour of triple-negative breast cancer (TNBC) cells. Acting as redox-active nanostructures, pTA nanospheres suppress proliferation and induce mechanoregulatory changes, including altered nuclear morphology, cytoskeletal disassembly, and diminished cell polarity. Specifically, pTA treatment causes spatial mislocalization of MT1-MMP from the invasive front to the perinuclear zone, disrupting its colocalization with F-actin and reducing its matrix-degrading capacity. High-resolution STED and TEM imaging reveal vimentin network collapse and mitochondrial redistribution along microtubules. Metabolic profiling shows a marked decline in oxidative phosphorylation-linked ATP production. Despite these functional disruptions, cleaved caspase-3 remains undetectable, indicating a non-apoptotic, cytostatic state accompanied by autophagy and redox signalling compensation. These findings demonstrate that pTA nanospheres exert redox-driven mechanoregulation in TNBC cells, limiting their invasive potential without inducing cell death, and highlight their promise as a non-lethal nanotherapeutics approach for post-surgical or adjuvant control of metastatic progression.
聚单宁酸(pTA)纳米球由天然单宁酸分子组装而成,具有很强的细胞内抗氧化活性,可有效调节三阴性乳腺癌(TNBC)细胞的侵袭行为。作为氧化还原活性纳米结构,pTA纳米球抑制增殖并诱导机械调节变化,包括核形态改变、细胞骨架解体和细胞极性减弱。具体来说,pTA治疗导致MT1-MMP从侵袭前沿到核周区域的空间错定位,破坏其与f -肌动蛋白的共定位,降低其基质降解能力。高分辨率STED和TEM成像显示静脉蛋白网络崩溃和线粒体沿微管重新分布。代谢分析显示氧化磷酸化相关的ATP产生明显下降。尽管存在这些功能破坏,但切割后的caspase-3仍然无法检测到,这表明caspase-3处于非凋亡、细胞抑制状态,并伴有自噬和氧化还原信号补偿。这些发现表明,pTA纳米球在TNBC细胞中发挥氧化还原驱动的机制调节作用,在不诱导细胞死亡的情况下限制了它们的侵袭潜力,并突出了它们作为手术后或辅助控制转移进展的非致死性纳米治疗方法的前景。
{"title":"Redox-driven mechanoregulation of invasive TNBC cells using poly(tannic acid) nanospheres","authors":"Minhee Ku ,&nbsp;Suhui Jeong ,&nbsp;Nara Yoon ,&nbsp;Hwain Myeong ,&nbsp;Jinwon Kwon ,&nbsp;Jaemoon Yang ,&nbsp;Sungbaek Seo","doi":"10.1016/j.nantod.2025.102907","DOIUrl":"10.1016/j.nantod.2025.102907","url":null,"abstract":"<div><div>Poly(tannic acid) (pTA) nanospheres, assembled from natural tannic acid molecules, exhibit strong intracellular antioxidant activity and effectively modulate the invasive behaviour of triple-negative breast cancer (TNBC) cells. Acting as redox-active nanostructures, pTA nanospheres suppress proliferation and induce mechanoregulatory changes, including altered nuclear morphology, cytoskeletal disassembly, and diminished cell polarity. Specifically, pTA treatment causes spatial mislocalization of MT1-MMP from the invasive front to the perinuclear zone, disrupting its colocalization with F-actin and reducing its matrix-degrading capacity. High-resolution STED and TEM imaging reveal vimentin network collapse and mitochondrial redistribution along microtubules. Metabolic profiling shows a marked decline in oxidative phosphorylation-linked ATP production. Despite these functional disruptions, cleaved caspase-3 remains undetectable, indicating a non-apoptotic, cytostatic state accompanied by autophagy and redox signalling compensation. These findings demonstrate that pTA nanospheres exert redox-driven mechanoregulation in TNBC cells, limiting their invasive potential without inducing cell death, and highlight their promise as a non-lethal nanotherapeutics approach for post-surgical or adjuvant control of metastatic progression.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102907"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145263043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silico-driven drug discovery: A paradigm shift for nanomedicine science and industry 硅驱动的药物发现:纳米医学科学和工业的范式转变
IF 10.9 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Pub Date : 2026-02-01 Epub Date: 2025-10-28 DOI: 10.1016/j.nantod.2025.102918
Yadong Jin , Yiting Zhou , Zhuo Xu , Zhifei Jin , Huan Meng , Suping Li , Liang Yan , Hui Wang , Jia-Jia Zheng , Xingfa Gao , Yuliang Zhao
The integration of artificial intelligence (AI) into drug discovery has evolved from early computer-aided design to advanced AI-driven methodologies, laying the foundation for a transformative paradigm: Silico-driven Drug Discovery (SDD). Unlike conventional approaches where AI supports isolated stages, SDD treats the entire research process, including literature understanding, hypothesis generation, molecular design, and experimental validation, as a unified, potentially autonomous system. This review proposes the THINK–BUILD–OPERATE (TBO) architecture as a universal framework for implementing SDD and outlines its six-level automation pathway from human-led to fully autonomous discovery. We highlight nanomedicine as an optimal frontier for SDD due to its well-defined theoretical foundations, abundant multi-omics and pharmacological data, and supportive regulatory shifts. By integrating domain-specific toolchains, large-scale AI models, and orchestrated self-driving laboratories, SDD can accelerate complex, multidisciplinary research while reducing costs and timelines. We further identify key challenges including AI model reliability, infrastructure interoperability, and automated laboratory versatility that must be addressed to achieve this vision. Ultimately, the convergence of AI, advanced laboratory automation, and global research networking holds the potential to transform drug discovery into an industrial-scale, programmable scientific enterprise.
人工智能(AI)与药物发现的整合已经从早期的计算机辅助设计发展到先进的人工智能驱动方法,为一种变革性范式奠定了基础:硅驱动药物发现(SDD)。与人工智能支持孤立阶段的传统方法不同,SDD将整个研究过程(包括文献理解、假设生成、分子设计和实验验证)视为一个统一的、潜在的自治系统。本文提出了THINK-BUILD-OPERATE (TBO)架构作为实现SDD的通用框架,并概述了其从人类主导到完全自主发现的六级自动化路径。由于其明确的理论基础、丰富的多组学和药理学数据以及支持性的调控转变,我们强调纳米医学是SDD的最佳前沿。通过集成特定领域的工具链、大规模人工智能模型和精心安排的自动驾驶实验室,SDD可以加速复杂的多学科研究,同时降低成本和时间。我们进一步确定了实现这一愿景必须解决的关键挑战,包括人工智能模型可靠性、基础设施互操作性和自动化实验室的多功能性。最终,人工智能、先进实验室自动化和全球研究网络的融合有可能将药物发现转变为工业规模、可编程的科学企业。
{"title":"Silico-driven drug discovery: A paradigm shift for nanomedicine science and industry","authors":"Yadong Jin ,&nbsp;Yiting Zhou ,&nbsp;Zhuo Xu ,&nbsp;Zhifei Jin ,&nbsp;Huan Meng ,&nbsp;Suping Li ,&nbsp;Liang Yan ,&nbsp;Hui Wang ,&nbsp;Jia-Jia Zheng ,&nbsp;Xingfa Gao ,&nbsp;Yuliang Zhao","doi":"10.1016/j.nantod.2025.102918","DOIUrl":"10.1016/j.nantod.2025.102918","url":null,"abstract":"<div><div>The integration of artificial intelligence (AI) into drug discovery has evolved from early computer-aided design to advanced AI-driven methodologies, laying the foundation for a transformative paradigm: Silico-driven Drug Discovery (SDD). Unlike conventional approaches where AI supports isolated stages, SDD treats the entire research process, including literature understanding, hypothesis generation, molecular design, and experimental validation, as a unified, potentially autonomous system. This review proposes the THINK–BUILD–OPERATE (TBO) architecture as a universal framework for implementing SDD and outlines its six-level automation pathway from human-led to fully autonomous discovery. We highlight nanomedicine as an optimal frontier for SDD due to its well-defined theoretical foundations, abundant multi-omics and pharmacological data, and supportive regulatory shifts. By integrating domain-specific toolchains, large-scale AI models, and orchestrated self-driving laboratories, SDD can accelerate complex, multidisciplinary research while reducing costs and timelines. We further identify key challenges including AI model reliability, infrastructure interoperability, and automated laboratory versatility that must be addressed to achieve this vision. Ultimately, the convergence of AI, advanced laboratory automation, and global research networking holds the potential to transform drug discovery into an industrial-scale, programmable scientific enterprise.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102918"},"PeriodicalIF":10.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145412556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nano Today
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1